OSTX
OS Therapies Incorporated
1.70$
+0.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +22.1% | +31.4% | +28.0% | +47.3% | +180.1% | -23.3% | +142.6% | -13.2% | -23.6% | +6.7% | +35.6% | |
| – | +22.4% | +31.8% | +28.2% | +47.5% | +180.8% | -26.0% | -13.2% | -34.7% | -85.7% | +175.6% | +296.8% | |
| – | +142.7% | +157.1% | -5.3% | +1,857.4% | +197.8% | -46.3% | -5.7% | -33.0% | -85.6% | +240.0% | -77.7% | |
| – | +142.7% | +157.1% | -5.3% | +1,857.4% | +197.8% | -46.3% | -5.7% | -33.0% | -85.6% | +240.0% | -77.7% | |
| – | – | – | – | +24.7% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | +4,401.7% | -1.8% | -1.9% | -1.9% | -1.9% | |
| – | +7.1% | +7.0% | +7.0% | -90.5% | +76.1% | +78.5% | -57.8% | +19.3% | +204.7% | +40.1% | +13.9% | |
| – | +162.7% | +7.0% | +7.0% | -90.9% | +79.0% | -23.6% | -2.2% | +19.9% | +183.8% | +44.1% | +21.8% | |
| – | – | +6.5% | +7.3% | – | – | – | – | – | – | – | – | |
| – | +7.0% | +3.1% | +4.5% | -39.4% | -6.2% | -2.7% | +67.2% | +24.8% | +194.5% | +53.3% | +23.9% | |
| – | – | – | – | – | – | -615.9% | – | -30.3% | -229.5% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -13.2% | +0.0% | +2.7% | -22.8% | +678.6% | -82.8% | +18.2% | +27.2% | -8.5% | +32.2% | +13.5% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.